CPHI 2025 - Great exchanges to promote the use of Rondol vertical extruders and optimize the production of both Pharma active principles and Drug formulations

The Rondol team was delighted to to participate in CPHI 2025 in Frankfurt, an amazing platform for innovation, collaboration, and industry insight with thousands of attendees and exhibitors from across the pharmaceutical industry value chain.

Thank you SEQENS, Ardena, BASF Pharma Solutions, Evonik, Ropack Pharma Solutions, ACIC Pharmaceuticals Inc., SK Pharmteco & 5N Plus inc.  for these invaluable discussions that highlighted the rapidly growing interest in Vertical Hot Melt Extrusion (HME) as an enabling technology for improving the production of pharmaceutical active ingredients (APIs), enhancing drug solubility and optimizing drug formulation processes, including both immediate- and controlled-release profiles.

Rondol's team with Gregory Lambert (R&D Director - Seqens)

And a special shoutout to our friends of Recipharm who invited us to join the (very successful) celebration of their 30th anniversary. 

Rondol's team with Dr. Uwe Hanenberg (Recipharm)

See more about our Pharma applications.

For any Pharma inquiry, please contact Mael Gallas at mael@rondol.com.